Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from EVE Health Group Limited ( (AU:EVE) ).
EVE Health Group Limited has applied to the ASX for quotation of 64.7 million new fully paid ordinary shares, with an issue date of March 20, 2026. The move reflects a significant expansion of the company’s quoted capital base, which may influence its liquidity and ownership structure, though the announcement provides no additional context on the use of funds or strategic rationale.
The company’s filing, made on March 23, 2026, formalizes the listing of these securities that were previously flagged to the market in earlier transactional disclosures. Stakeholders will likely assess how the enlarged share count affects valuation metrics and market perceptions once the new securities commence trading.
The most recent analyst rating on (AU:EVE) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on EVE Health Group Limited stock, see the AU:EVE Stock Forecast page.
More about EVE Health Group Limited
EVE Health Group Limited is an Australian-listed company on the ASX under the code EVE. The announcement does not provide details on its specific industry segment, products, or services, nor its primary market focus.
Average Trading Volume: 304,171
Technical Sentiment Signal: Sell
Current Market Cap: A$5.41M
Find detailed analytics on EVE stock on TipRanks’ Stock Analysis page.